PHI with Diabetic glomerulonephritis
How does this condition affect your private health insurance?
Diabetic glomerulonephritis, commonly known as diabetic nephropathy, is a severe complication of both type 1 and type 2 diabetes. It involves progressive damage to the glomeruli, the kidney's filtering units. Persistently high blood glucose levels cause structural alterations in these filters, impairing their ability to remove waste products and excess fluid. This leads to symptoms like proteinuria, hypertension, and ultimately, chronic kidney disease, often advancing to end-stage renal disease (ESRD) requiring dialysis or transplantation. Early detection, rigorous blood glucose and blood pressure control, and specific medications are vital to slow its progression and prevent irreversible kidney failure.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Years of gradual, often asymptomatic progression of kidney damage, typically presenting with microalbuminuria.
Duration of Illness (Lifetime)
Lifelong, chronic, and progressive condition once established, potentially leading to end-stage renal disease.
Cost of Treatment (Initial)
Moderate, including regular monitoring, medication for blood glucose and blood pressure control (e.g., ACE inhibitors/ARBs), and dietary adjustments.
Cost of Treatment (Lifetime)
Very high, escalating significantly if progression to end-stage renal disease requires dialysis or kidney transplantation, alongside ongoing medication and specialist visits.
Mortality Rate
Increased probability of premature death, particularly due to cardiovascular complications and end-stage renal disease if untreated or poorly managed.
Risk of Secondary Damages
High probability of secondary damage, including cardiovascular disease, neuropathy, retinopathy, anemia, bone disease, and severe hypertension.
Probability of Full Recovery
Low; while progression can be slowed significantly with aggressive management, complete reversal of established damage is rare. Focus is on disease management and prevention of progression.
Underlying Disease Risk
100%, as it is a direct complication of underlying Type 1 or Type 2 diabetes mellitus.